Inventor
JORAND-LEBRUN CATHERINE
FR41 patents
⚠️ This page may combine multiple inventors who share the name “JORAND-LEBRUN CATHERINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK PATENT GMBH
20 patentsUS11001561B2May 11, 2021
Pyrimidinone derivatives as SHP2 antagonists
MERCK PATENT GMBH26 citations93
US9969710B2May 15, 2018
Heteroaryl compounds as IRAK inhibitors and uses thereof
MERCK PATENT GMBH41 citations93
US11033547B2Jun 15, 2021
Carboxamide-pyrimidine derivatives as SHP2 antagonists
MERCK PATENT GMBH26 citations92
US9815836B2Nov 14, 2017
Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof
MERCK PATENT GMBH7 citations84
US9708324B2Jul 18, 2017
Macrocyclic compounds as IRAK1/4 inhibitors and uses thereof
MERCK PATENT GMBH7 citations84
US9624246B2Apr 18, 2017
Pyridazinone macrocycles as IRAK inhibitors and uses thereof
MERCK PATENT GMBH8 citations84
US10517872B2Dec 31, 2019
Pyridazinone macrocycles as IRAK inhibitors and uses thereof
MERCK PATENT GMBH2 citations73
US9567320B2Feb 14, 2017
Pyridazinone-amides derivatives
MERCK PATENT GMBH4 citations72
US10064861B2Sep 4, 2018
Macrocyclic pyridazinone derivatives
MERCK PATENT GMBH4 citations70
US9790221B2Oct 17, 2017
Heteroaryl compounds as IRAK inhibitors and uses thereof
MERCK PATENT GMBH4 citations70
US11542246B2Jan 3, 2023
Quinoline compounds as IRAK inhibitors and uses thereof
MERCK PATENT GMBH0 citations62
US11702392B2Jul 18, 2023
Pyrimidinone derivatives as SHP2 antagonists
MERCK PATENT GMBH0 citations61
US11696916B2Jul 11, 2023
Carboxamide-pyrimidine derivatives as SHP2 antagonists
MERCK PATENT GMBH0 citations60
US11873303B2Jan 16, 2024
Substituted pyrazoles as type II IRAK inhibitors
MERCK PATENT GMBH0 citations51
US10392375B2Aug 27, 2019
Heteroaryl compounds as IRAK inhibitors and uses thereof
MERCK PATENT GMBH0 citations51
US10059701B2Aug 28, 2018
Heteroaryl compounds as IRAK inhibitors and uses thereof
MERCK PATENT GMBH0 citations51
US10030013B2Jul 24, 2018
Heteroaryl compounds as IRAK inhibitors and uses thereof
MERCK PATENT GMBH0 citations49
US9550794B2Jan 24, 2017
Macrocyclic pyridazinone derivatives
MERCK PATENT GMBH0 citations49
US10314841B2Jun 11, 2019
Substituted pyrazoles as IRAK inhibitors
MERCK PATENT GMBH0 citations41
US9975902B2May 22, 2018
Compounds for the inhibition of cyclophilins and uses thereof
MERCK PATENT GMBH0 citations41
MERCK SERONO SA
6 patentsUS9447055B1Sep 20, 2016
α-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
MERCK SERONO SA17 citations92
US10259795B2Apr 16, 2019
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
MERCK SERONO SA7 citations83
US9834528B2Dec 5, 2017
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
MERCK SERONO SA5 citations83
US8008302B2Aug 30, 2011
N-hydroxyamide derivatives and use thereof
MERCK SERONO SA0 citations51
US7947851B2May 24, 2011
1,1′-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors
MERCK SERONO SA1 citations51
US7973039B2Jul 5, 2011
Sulfonyl amino cyclic derivatives and use thereof
MERCK SERONO SA0 citations41
SERONO LAB
4 patentsUS7589232B2Sep 15, 2009
Alkynyl aryl carboxamides
SERONO LAB4 citations62
US7312358B2Dec 25, 2007
Pharmaceutically active sulfanilide derivatives
SERONO LAB3 citations61
US7456201B2Nov 25, 2008
Pharmaceutically active compounds and methods of use
SERONO LAB0 citations45
US7557136B2Jul 7, 2009
Pyrrolidine derivatives as oxytocin antagonists
SERONO LAB0 citations38
APPLIED RESEARCH SYSTEMS
2 patentsSWINNEN DOMINIQUE
2 patentsObsEva SA
2 patentsUS10555934B2Feb 11, 2020
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
ObsEva SA4 citations71
US11524003B2Dec 13, 2022
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
ObsEva SA0 citations61